Clinical Nodal Stage Is an Independently Significant Predictor of Distant Failure in Patients with Squamous Cell Carcinoma of the Larynx

Annals of Surgery

Volumn 238, Issue 3, 2003, Pages 412-422

  Matsuo, Jeannette Marie S ^a   Patel, Snehal G ^a   Sing, Bhuvanesh ^a   Wong, Richard J ^a   Boyle, Jay O ^a   Kraus, Dennis H ^a   Shaha, Ashok R ^a   Zelefsky, Michael J ^a   Pfister, David G ^a   Shah, Jatin P ^a   Urist, Marshall M ^b   Donahue, Philip E ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; CALCULATION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CELL TYPE; CONFERENCE PAPER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; ARTICLE; DISEASE FREE SURVIVAL; FACTUAL DATABASE; GLOTTIS; LARYNX TUMOR; LYMPH NODE; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; STATISTICS; TIME;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; TIME FACTORS;

EID: 0842289160     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Vikram B, Strong EW, Shah JP, et al. Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg. 1984;6:730-733.
2. Calhoun KH, Fulmer P, Weiss R, et al. Distant metastases from head and neck squamous cell carcinomas. Laryngoscope. 1994;104:1199-1205.
3. Kotwall C, Sako K, Razack MS, et al. Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg. 1987;154:439-442.
4. Spector GJ. Distant metastases from laryngeal and hypopharyngeal cancer. ORL J Otorhinolaryngol Relat Spec. 2001;63:224-228.
5. Leemans CR, Tiwari R, Nauta JJ, et al. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer. 1993;71:152-456.
6. Jakobsen J, Hansen O, Jorgensen KE, et al. Lymph node metastases from laryngeal and pharyngeal carcinomas-calculation of burden of metastasis and its impact on prognosis. Acta Oncol. 1998;37:489-493.
7. Dennington ML, Carter DR, Meyers AD. Distant metastases in head and neck epidermoid carcinoma. Laryngoscope. 1980;90:196-201.
8. Nishijima W, Takooda S, Tokita N, et al. Analyses of distant metastases in squamous cell carcinoma of the head and neck and lesions above the clavicle at autopsy. Arch Otolaryngol Head Neck Surg. 1993;119:65-68.
9. Zbaren P, Lehmann W. Frequency and sites of distant metastases in head and neck squamous cell carcinoma. An analysis of 101 cases at autopsy. Arch Otolaryngol Head Neck Surg. 1987;113:762-764.
10. Alvi A, Johnson JT. Development of distant metastasis after treatment of advanced-stage head and neck cancer. Head Neck. 1997;19:500-505.
11. Brasilino DC. Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head Neck. 1998;20:16-21.
12. Myers JN, Greenberg JS, Mo V, et al. Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer. 2001;92:3030-3036.
13. Fortin A, Couture C, Doucet R, et al. Does histologic grade have a role in the management of head and neck cancers? J Clin Oncol. 2001;19:4107-4116.
14. Leon X, Quer M, Orus C, et al. Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck. 2000;22:680-686.
15. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000;355:949-955.
16. Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer. 1995;71:83-91.
17. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med. 1991;324:1685-1690.
18. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst. 1996;88:890-899.
19. Domenge C, Hill C, Lefebvre JL, et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tete et du Cou (GETTEC). Br J Cancer. 2000;83:1594-1598.
20. Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol. 2000;18:1458-1464.
21. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91:2081-2086.
22. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798-1804.
23. Wendt TG, Grabenbauer GG, Rodel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol. 1998;16:1318-1324.
24. Laramore GE, Scott CB, al Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys. 1992;23:705-713.
25. Lam P, Yuen AP, Ho CM, et al. Prospective randomized study of post-operative chemotherapy with levamisole and UFT for head and neck carcinoma. Eur J Surg Oncol. 2001;27:750-753.
26. Doweck I, Robbins KT, Vieira F. Analysis of risk factors predictive of distant failure after targeted chemoradiation for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2001;127:1315-1318.